U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H24ClFN4O3
Molecular Weight 446.902
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GEFITINIB

SMILES

COC1=C(OCCCN2CCOCC2)C=C3C(NC4=CC(Cl)=C(F)C=C4)=NC=NC3=C1

InChI

InChIKey=XGALLCVXEZPNRQ-UHFFFAOYSA-N
InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
GEFITINIB
EMA EPAR   INN   JAN   MART.   MI   ORANGE BOOK   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
gefitinib [INN]
Common Name English
GEFITINIB [USAN]
Common Name English
NSC-759856
Code English
4-QUINAZOLINAMINE, N-(3-CHLORO-4-FLUOROPHENYL)-7-METHOXY-6-(3-4-MORPHOLIN)PROPOXY)-
Common Name English
GEFITINIB [EMA EPAR]
Common Name English
ZD-1839
Code English
GEFITINIB [VANDF]
Common Name English
IRESSA
Brand Name English
Gefitinib [WHO-DD]
Common Name English
GEFITINIB [JAN]
Common Name English
GEFITINIB [EP MONOGRAPH]
Common Name English
GEFITINIB [ORANGE BOOK]
Common Name English
GEFITINIB [MART.]
Common Name English
GEFITINIB [MI]
Common Name English
ZD1839
Code English
Classification Tree Code System Code
EU-Orphan Drug EU/3/18/2075
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
WHO-ATC L01XE02
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
NCI_THESAURUS C129825
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
WHO-VATC QL01XE02
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
EMA ASSESSMENT REPORTS IRESSA (AUTHORIZED: CARCINOMA, NON-SMALL-CELL LUNG)
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
NDF-RT N0000175605
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
NDF-RT N0000175076
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
NCI_THESAURUS C1967
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
FDA ORPHAN DRUG 443014
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
LIVERTOX NBK548839
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
Code System Code Type Description
SMS_ID
100000091738
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
WIKIPEDIA
GEFITINIB
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
ChEMBL
CHEMBL939
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
DAILYMED
S65743JHBS
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
EVMPD
SUB20637
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
DRUG BANK
DB00317
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
EPA CompTox
DTXSID8041034
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
FDA UNII
S65743JHBS
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
NCI_THESAURUS
C1855
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
MERCK INDEX
m5682
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY Merck Index
MESH
C419708
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
INN
8204
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
RXCUI
328134
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY RxNorm
IUPHAR
4941
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
CHEBI
49668
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
USAN
NN-73
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
CAS
184475-35-2
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
NSC
759856
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
PUBCHEM
123631
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
DRUG CENTRAL
1282
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
LACTMED
Gefitinib
Created by admin on Fri Dec 15 15:42:15 UTC 2023 , Edited by admin on Fri Dec 15 15:42:15 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of GEFITINIB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966